Bacterial type VI secretion is an offensive and defensive weapon that utilizes a molecular warhead to inject toxins into neighboring cells. In this issue of Cell, Whitney et al. report a new class of toxin that disrupts the core metabolism of recipient cells and uncover a surprising requirement for EF-Tu.
Nowhere is life more fiercely competitive than in the invisible world of bacteria and other microbes. Vast in numbers, these diminutive creatures disable their competitors by assailing each other with a range of weapons that include dispersible small molecules (antibiotics) and protein toxins (e.g., colicins). Perhaps the most cunning weapon is the type VI secretion (T6S) system of Vibrio, Pseudomonas, and certain other Gram-negative bacteria, which forms a miniscule springloaded dagger-a phage-tail-like contractile apparatus, complete with a molecularly poisoned sharp tip-to instantaneously inject protein toxins at point-blank range into neighboring cells. Evoking the infamous Umbrella Murder, in which Bulgarian dissident Georgi Markov was assassinated by a ricin-laced projectile fired from an umbrella, the spear-gun-like T6S system fires into eukaryotic cells and bacteria alike, breaching their membranes and delivering toxic effector molecules with different modes of action. In this issue of Cell, Whitney et al. (2015) report that a recently discovered effector poisons cells differently from previously known effectors and, surprisingly, requires the translation elongation factor EF-Tu to intoxicate target cells.
The first functionally characterized T6S system, from V. cholerae, was revealed by its role in warding off predation by amoebae (Pukatzki et al., 2006) , but T6S systems are increasingly viewed as part of an arsenal that bacteria use against one another. Indeed, bacteria can even be seen duking it out, repeatedly attacking and counterattacking in a process termed ''dueling'' (Basler et al., 2013) . Characterized T6S effector molecules include lipases that target the bacterial membrane, peptidoglycan hydrolases that degrade the cell wall, and nucleases that act on the nucleoid ( Figure 1A ) (Durand et al., 2014 An enduring question is where in the target cell the warhead of effector proteins is initially delivered. Is it to the periplasm only, to the cytoplasm, or to both? In principle, the phage-tail-like tube of the T6S apparatus is long enough to penetrate 500 nm into a target cell (Basler et al., 2012; Ho et al., 2014) , which could allow for direct delivery into the cytoplasm. But lipases and peptidoglycan hydrolases only need to reach the periplasmic space, and the cell wall might present a barrier to mechanical puncture. On the other hand, nuclease effectors and the Tse6 NAD(P) + hydrolase require entry into the cytoplasm to reach their targets. Until an attacking cell is visualized during the act of firing into its target, we will be forced to make inferences about how the toxins reach their targets. However, a surprising requirement of Tse6 sheds light on the mechanism of effector delivery for at least one toxin. While investigating the interaction of Tse6 with other cellular proteins, the authors discovered that the NAD(P) + hydrolase forms a complex with the translation elongation factor EF-Tu. The interaction is strong and specific, and substitution of a single amino acid, identified in a Tse6-EF-Tu co-crystal structure, abolished Tse6 binding to EF-Tu. Remarkably, when this mutant Tse6 was introduced into attacker cells, they could no longer disable target cells, suggesting a specific requirement for EF-Tu in the delivery or activity of the toxin.
How are we to understand the unexpected requirement for EF-Tu in Tse6 toxicity? By using the non-interacting mutant, the authors ruled out several possibilities. Interaction with EF-Tu is required neither for the stability of the Tse6 protein nor for its NAD(P) + hydrolase activity. They also showed that it is not required for export of Tse6 from attacker cells. Thus, by a process of elimination, the authors conclude that the binding of Tse6 to EF-Tu facilitates the entry of Tse6 into the cytoplasm of target cells.
In their model, Tse6 is delivered by the T6S system into the periplasm of a target cell along with its chaperone (Eag6), which shields its hydrophobic transmembrane regions. Tse6 then inserts into the cytoplasmic membrane of the target cell and is granted entry to the cytoplasm by progressively interacting with EF-Tu as it crosses the membrane ( Figure 1B) . Thus, the T6S system does not deliver the toxin into the cytoplasm. Rather, Tse6 only needs to reach the cytoplasmic membrane of the target cell, where it then becomes trapped in the cytoplasm by EF-Tu. If this model is correct, a complementary mutant of EF-Tu that is specifically blocked in binding to Tse6 would be expected to confer immunity to the toxin in target cells. The Tse6 results do not exclude the possibility that other T6S effectors with cytoplasmic targets are directly delivered to the target cytoplasm, as Tse6 may have evolved a special, EF-Tu-dependent mode of cytoplasmic entry that is not shared by other cytoplasmic effectors. Perhaps other effectors, such as the T6S-delivered nuclease of P. aeruginosa (Hachani et al., 2014) , are injected directly into the cytoplasm without the aid of target cell proteins. Finally, we note that T6S systems are not restricted to the delivery of toxins, as in the fascinating case of the transfer of proteins that mediate self/non-self identity between cells of Proteus mirabilis (Wenren et al., 2013) .
Figure 1. T6S Effectors and Their Sites of Action
(A) The T6S apparatus delivers effectors to the periplasmic space of Gram-negative target bacteria. It is unknown whether it can also breach the peptidoglycan and deliver effectors directly to the cytoplasm. Some effectors, such as lipases and peptidoglycan hydrolases (amidases or glycosylases), act within the periplasmic space. Others, such as nucleases and the newly discovered NAD(P) + hydrolase Tse6, act in the cytoplasm. (B) Model for delivery and translocation of the Tse6 effector. When loaded on the T6S apparatus, the hydrophobic transmembrane regions of Tse6 are protected by its chaperone, Eag6 (left). Either in transit or once delivered, Eag6 dissociates from Tse6, exposing its three transmembrane regions. Tse6 then partitions into the cytoplasmic membrane, where its C-terminal effector domain is drawn into the cytoplasm by association with cytoplasmic EF-Tu (center). After being pulled into the cytoplasm, the effector intoxicates the target cell via its NAD(P) + hydrolase activity (right).
The current obesity epidemic has focused a great deal of attention on mechanisms controlling energy balance. While diet and nutrient absorption affect energy intake, on the other side of the equation, energy expenditure is determined by basal metabolism, physical activity, and adaptive thermogenesis. Given various challenges in modulating these energy balance mechanisms to combat human obesity, many efforts have concentrated on how it might be possible to achieve weight loss through increased thermogenesis. In this issue of Cell, Kazak et al. describe a previously unrecognized molecular pathway for thermogenesis in fat cells.
Non-shivering thermogenesis occurs primarily in brown adipose tissue in rodents, but also has been detected in so called ''beige'' adipocytes, thought to reside mainly in subcutaneous fat tissue interspersed with classic white adipocytes (Wu et al., 2012; Young et al., 1984) . Much of human thermogenic fat most closely resembles the rodent beige adipose tissue (Shinoda et al., 2015) . Beige and brown adipocytes both express uncoupling protein 1 (Ucp1), which resides on the inner mitochondrial membrane. While the electron transport chain drives protons into the intermembrane space in mitochondria, creating a proton gradient across the inner membrane to drive the synthesis of ATP ( Figure 1A ), Ucp1 creates a pore through which protons disperse into the mitochondrial matrix, thereby generating heat and uncoupling ATP synthesis ( Figure 1B) . Cold exposure or increased sympathetic activity stimulated by feeding activates thermogenesis through adrenergic activation of Ucp1 expression (Ricquier et al., 1986; Scarpace et al., 1997) . Although Ucp1 is well established as an important component of thermogenesis, investigators have long known that the transcriptional regulation of Ucp1 cannot fully explain thermic responses. For example, the thermic effect of feeding is far too rapid to be explained by a transcriptional effect alone (Scarpace et al., 1997) . Furthermore, Ucp1 knockout mice can adapt to chronic cold exposure when the temperature transition is gradual (Golozoubova et al., 2001) . Nonshivering thermogenesis has also been characterized in muscle, where Sarcolipin (Sln) uncouples ATP hydrolysis from Ca 2+ transport, thereby creating a futile cycle that generates heat (Bal et al., 2012) . However, Ucp1/Sln double-knockout mice still retain the ability to maintain thermal regulation when slowly adapted to the cold (Rowland et al., 2015) , leaving a gap in our understanding of how thermogenesis occurs.
To fill in this gap, Bruce Spiegelman and his colleagues, including mass spec expert Steven Gygi, conducted proteomic and genomic studies comparing beige, white, and brown adipocytes (Kazak et al., 2015) . KEGG pathway analysis of proteins preferentially expressed in beige versus brown fat revealed several components of the arginine/creatine and proline metabolism pathways. These findings were confirmed when the analysis was limited to proteins specifically enriched in purified mitochondrial fractions. Proteins that promote both creatine synthesis and phosphorylation, including the mitochondrial creatine kinase CMKT2 and the majority of ATP synthase subunits, were elevated in mitochondria from beige fat. Creatine kinase (CK) activity was also specifically induced in beige fat mitochondria derived from mice exposed to cold, suggesting that it is somehow under adrenergic control. Together, these findings hinted that a futile creatine phosphorylation and dephosphorylation cycle might somehow be involved in generating heat specifically in mitochondria from beige adipocytes.
CK catalyzes the phosphorylation of creatine using ATP, generating phosphocreatine and ADP. In tissues with high ATP demands, such as skeletal muscle, the high-energy phosphate bound to creatine can be transferred to ADP to generate cytosolic ATP (Wyss and Kaddurah-Daouk, 2000) . If creatine were serving to regenerate mitochondrial ATP through classical CK-mediated phosphotransferase activity, it would be expected to boost respiration as a molar equivalent
